search icon
elym-img

Eliem Therapeutics Inc, Common Stock

ELYM

NMQ

$

+$

(%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$342.68M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
0
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
-0.38
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$2.52 L
$11.55 H
$

About Eliem Therapeutics Inc, Common Stock

Eliem Therapeutics, Inc., a biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in psychiatry, epilepsy, chronic pain, and other disorders of the peripheral and central nervous systems. The company was incorporated in 2018 and is headquartered in Wilmington, Delaware. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameELYMSectorS&P500

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Gross Profit-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Gross Margin-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Operating Expenses4.70M11.77M35.67M45.13M37.41M[{"date":"2019-12-31","value":10.4,"profit":true},{"date":"2020-12-31","value":26.07,"profit":true},{"date":"2021-12-31","value":79.03,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":82.88,"profit":true}]
Operating Income(7.45M)(20.93M)(35.67M)(45.13M)(21.47M)[{"date":"2019-12-31","value":-744600000,"profit":false},{"date":"2020-12-31","value":-2092500000,"profit":false},{"date":"2021-12-31","value":-3567200000,"profit":false},{"date":"2022-12-31","value":-4513500000,"profit":false},{"date":"2023-12-31","value":-2146600000,"profit":false}]
Total Non-Operating Income/Expense---1.27M(9.03M)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-713.51,"profit":false}]
Pre-Tax Income(6.55M)(20.67M)(47.48M)(45.24M)(35.12M)[{"date":"2019-12-31","value":-654700000,"profit":false},{"date":"2020-12-31","value":-2066800000,"profit":false},{"date":"2021-12-31","value":-4748000000,"profit":false},{"date":"2022-12-31","value":-4524400000,"profit":false},{"date":"2023-12-31","value":-3511900000,"profit":false}]
Income Taxes(2.75M)(9.16M)(66.56K)109.00K(21.47K)[{"date":"2019-12-31","value":-2522.94,"profit":false},{"date":"2020-12-31","value":-8401.83,"profit":false},{"date":"2021-12-31","value":-61.06,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-19.69,"profit":false}]
Income After Taxes---(45.35M)(35.10M)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-4535300000,"profit":false},{"date":"2023-12-31","value":-3509753400,"profit":false}]
Income From Continuous Operations(6.55M)(20.67M)(95.08M)(45.24M)(39.24M)[{"date":"2019-12-31","value":-654700000,"profit":false},{"date":"2020-12-31","value":-2066800000,"profit":false},{"date":"2021-12-31","value":-9508300000,"profit":false},{"date":"2022-12-31","value":-4524400000,"profit":false},{"date":"2023-12-31","value":-3924000000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(3.80M)(11.51M)(47.48M)(45.35M)(35.12M)[{"date":"2019-12-31","value":-379700000,"profit":false},{"date":"2020-12-31","value":-1151000000,"profit":false},{"date":"2021-12-31","value":-4748000000,"profit":false},{"date":"2022-12-31","value":-4535300000,"profit":false},{"date":"2023-12-31","value":-3511900000,"profit":false}]
EPS (Diluted)--(4.21)(1.72)(0.72)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-421,"profit":false},{"date":"2022-12-31","value":-172,"profit":false},{"date":"2023-12-31","value":-72.25,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

ELYM
Cash Ratio 59.65
Current Ratio 60.41

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

ELYM
ROA (LTM) -24.54%
ROE (LTM) -38.35%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

ELYM
Debt Ratio Lower is generally better. Negative is bad. 0.02
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.98

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

ELYM
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 0.97
Price/FCF NM
EV/R 0.00
EV/Ebitda 0.58

FAQs

What is Eliem Therapeutics Inc share price today?

Eliem Therapeutics Inc (ELYM) share price today is $

Can Indians buy Eliem Therapeutics Inc shares?

Yes, Indians can buy shares of Eliem Therapeutics Inc (ELYM) on Vested. To buy Eliem Therapeutics Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ELYM stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Eliem Therapeutics Inc be purchased?

Yes, you can purchase fractional shares of Eliem Therapeutics Inc (ELYM) via the Vested app. You can start investing in Eliem Therapeutics Inc (ELYM) with a minimum investment of $1.

How to invest in Eliem Therapeutics Inc shares from India?

You can invest in shares of Eliem Therapeutics Inc (ELYM) via Vested in three simple steps:

  • Click on Sign Up or Invest in ELYM stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Eliem Therapeutics Inc shares
What is Eliem Therapeutics Inc 52-week high and low stock price?

The 52-week high price of Eliem Therapeutics Inc (ELYM) is $11.55. The 52-week low price of Eliem Therapeutics Inc (ELYM) is $2.52.

What is Eliem Therapeutics Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Eliem Therapeutics Inc (ELYM) is

What is Eliem Therapeutics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Eliem Therapeutics Inc (ELYM) is 0.97

What is Eliem Therapeutics Inc dividend yield?

The dividend yield of Eliem Therapeutics Inc (ELYM) is 0.00%

What is the Market Cap of Eliem Therapeutics Inc?

The market capitalization of Eliem Therapeutics Inc (ELYM) is $342.68M

What is Eliem Therapeutics Inc’s stock symbol?

The stock symbol (or ticker) of Eliem Therapeutics Inc is ELYM

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top